TY - JOUR
T1 - Positioning public health surveillance for observational studies and clinical trials
T2 - The St. Louis region-wide hospital-based violence intervention program data repository
AU - Mueller, Kristen L.
AU - Trolard, Anne
AU - Moran, Vicki
AU - Landman, Joshua M.
AU - Foraker, Randi
N1 - Publisher Copyright:
© 2020
PY - 2021/3
Y1 - 2021/3
N2 - Introduction: Firearm injuries are a public health epidemic in the United States, yet a comprehensive national database for patients with firearm injuries does not exist. Here we describe the methods for a study to develop and query a new regional database of all patients who present to a St. Louis level I trauma hospital with a violent injury, the St. Louis Hospital-Based Violence Intervention Program Data Repository (STL-HVIP-DR). We hypothesize that the STL-HVIP-DR will facilitate identification of patients at risk for violent injury and serve as a comparison population for participants enrolled in clinical trials. Methods: The STL-HVIP-DR includes all visits made for violent injury to four level I trauma hospitals in St. Louis, Missouri between January 1, 2010 and December 31, 2019. Two health systems representing the four participating hospitals executed a data sharing agreement to aggregate clinical data on firearm injuries, stabbings, and blunt assaults. Dataset variables include demographic hospital and timestamp, medical, and insurance information. Results: A preliminary cross-sectional query of the STL-HVIP-DR reveals 121,955 patient visits among the four partner level I trauma hospitals for a violent injury between 2010 and 2019. This includes over 18,000 patient visits for firearm injury. Discussion: The STL-HVIP-DR repository fills a critical gap regarding identification and outcomes among individuals who are violently injured, especially those with non-lethal firearm injuries. It is our hope that the methods presented in this paper will serve as a primer to develop repositories to help target violence prevention services in other regions.
AB - Introduction: Firearm injuries are a public health epidemic in the United States, yet a comprehensive national database for patients with firearm injuries does not exist. Here we describe the methods for a study to develop and query a new regional database of all patients who present to a St. Louis level I trauma hospital with a violent injury, the St. Louis Hospital-Based Violence Intervention Program Data Repository (STL-HVIP-DR). We hypothesize that the STL-HVIP-DR will facilitate identification of patients at risk for violent injury and serve as a comparison population for participants enrolled in clinical trials. Methods: The STL-HVIP-DR includes all visits made for violent injury to four level I trauma hospitals in St. Louis, Missouri between January 1, 2010 and December 31, 2019. Two health systems representing the four participating hospitals executed a data sharing agreement to aggregate clinical data on firearm injuries, stabbings, and blunt assaults. Dataset variables include demographic hospital and timestamp, medical, and insurance information. Results: A preliminary cross-sectional query of the STL-HVIP-DR reveals 121,955 patient visits among the four partner level I trauma hospitals for a violent injury between 2010 and 2019. This includes over 18,000 patient visits for firearm injury. Discussion: The STL-HVIP-DR repository fills a critical gap regarding identification and outcomes among individuals who are violently injured, especially those with non-lethal firearm injuries. It is our hope that the methods presented in this paper will serve as a primer to develop repositories to help target violence prevention services in other regions.
KW - Data repository
KW - Firearm injury
KW - Injury prevention
KW - Public health
UR - http://www.scopus.com/inward/record.url?scp=85098107337&partnerID=8YFLogxK
U2 - 10.1016/j.conctc.2020.100683
DO - 10.1016/j.conctc.2020.100683
M3 - Article
C2 - 33385095
AN - SCOPUS:85098107337
SN - 2451-8654
VL - 21
JO - Contemporary Clinical Trials Communications
JF - Contemporary Clinical Trials Communications
M1 - 100683
ER -